The parents of a terminally-ill British baby boy Charlie Gard, appeared in the high court in London on Monday after Great Ormond Street Hospital (GOSH) said it would let the courts re-examine claims that he could be treated, citing "fresh evidence" after US President Donald Trump and Pope Francis drew worldwide attention to the case.
Connie Yates, whose 11-month-old son Charlie Gard suffers from a form of mitochondrial disease, a rare genetic condition that causes progressive muscle weakness and brain damage, wants him to be sent to the United States for experimental therapy.
This is an undated hand out photo of Charlie Gard provided by his family, at Great Ormond Street Hospital, in London.
A boy named Arturito Estopinan in Baltimore was the first child to be given deoxynucleotide monophosphate, an experimental treatment that significantly extended the life of mice with the same condition as Arturito, known as TK2-related mitochondrial depletion syndrome.
"There is not a person alive who would not want to save Charlie", Francis said.
The decision was prompted by claims of "new information" from researchers at the Vatican's children's hospital.
Charlie's parents did not speak publicly after the hearing concluded.
Mr Gard yelled at a barrister representing Great Ormond Street bosses, saying: 'When are you going to start telling the truth?'
"Two worldwide hospitals and their researchers have told us in the last 24 hours that they have new evidence about experimental treatment proposed by them".
But they lost a lengthy legal battle after successive judges ruled in favour of doctors at GOSH, who argued the treatment would not improve the infant's quality of life and say his life-support machine should be switched off.
It led to Charlie's doctors on Friday requesting a new High Court hearing to assess whether the boy's life should be spared.
Amid public outrage, the U.K. High Court this week agreed to give Gard's case a new trial in light of new evidence concerning nucleoside bypass therapy presented by two global hospitals.
Foster told CNSNews.com that Charlie Gard's parents prefer that their son go to the United States for treatment.
Hospital administrators had kept him for months whilst fighting Charlie's parents in the High Court, Court of Appeal, Supreme Court, and even the European Court of Human Rights for permission to withdraw his life support without their consent.
Connie Yates told Sky News that she wanted judges to listen to experts on his condition who say the treatment might help.
She said she hoped the judge would take into account new evidence as when the decision was made previously, his chance was rated at being close to 0 percent but now this has been increased to 10 percent.
Charlie has a faulty RRM2B gene, which affects the cells responsible for energy production and breathing, meaning he can not move or breathe without a ventilator.
Professor Neena Modi, president of the Royal College of Paediatrics and Child Health, said in an open letter that only the family, the doctors treating Charlie, and now the legal teams involved know the details of complex issues that define his situation.
The hospital alternatively offered to arrange for the experimental drug to be shipped to Great Ormond Street and advise its staff on administering the drug.
Thanking supporters, Mr Gard said: "Let's get Charlie the treatment he needs".